跳至主要内容
临床试验/NCT03885323
NCT03885323已完成不适用

Safety and Efficacy of the Silk'n Toothbrush (ToothWave) Home Use Device for Reduction of Gingivitis, Dental Plaque and Calculus

Home Skinovations Ltd.2 个研究点 分布在 1 个国家目标入组 86 人开始时间: 2019年2月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
86
试验地点
2
主要终点
Gingival inflammation

研究概览

简要总结

The objective of the study is to evaluate the safety and efficacy of the home-use device Silk'n toothbrush (ToothWave) for the improvement in dental health through the reduction of plaque, gingivitis, and calculus.

详细描述

This is a single blind, prospective study aimed to evaluate the safety and efficacy of the Silk'n toothbrush in reduction of gingivitis, dental plaque and calculus.

The study includes 84 treatment sessions, twice a day, and 4 clinic visits over a period of 6 weeks.

One treatment group (Silk'n toothbrush - ToothWave) and 1 control group (an ADA approved power toothbrush (PTB)) will participate in the study.

For each patient, assessment data will be collected at baseline, 4 weeks, and at 6 weeks. The average data sets will be calculated for each group.

Treatment is defined as a timed 2 minutes of teeth brushing in a regular man-ner, twice a day (morning and evening). Brushing will be undertaken using the Silk'n toothbrush and standard fluoride toothpaste. The control group will use a regular PTB and standard fluoride toothpaste.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

盲法说明

Participants will not know if the toothbrush is a treatment or control brush. Outcome assessor will be blinded as well and will not know which product was dispensed to which participant.

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult subjects aged 18-70, that are in good health.
  • Subject must have:
  • Baseline gingivitis (MGI) score of at least 1.80, 2.
  • Dental Plaque mean score greater than 0.6 according to the RMNPI Index. 2.
  • Total Calculus deposits greater than 7 according to the Volpe-Manhold Index.
  • Have a minimum of 20 'scorable' teeth (excluding 3rd molars).
  • The subjects should understand the information provided about the investigative nature of the treatment, possible benefits and side effects. Subjects will sign the Informed Consent Form.
  • The subjects should be willing to comply with the study procedure and schedule, including the follow up visits.

排除标准

  • Current or history of oral cavity cancer or oropharyngeal cancer.
  • Pacemaker or internal defibrillator, or any other active electrical implant anywhere in the body.
  • Pregnant or nursing by subject report.
  • Any active condition in the oral cavity at the discretion of the investigator.
  • Any surgery in the oral cavity within 3 months prior to treatment, or before complete healing.
  • Subjects that do not brush regularly.
  • Any condition that might make it unsafe for the subject to participate in this study, at the discretion of the investigator.

结局指标

主要结局

Gingival inflammation

时间窗: 6 weeks

A reduction in the level of gingival inflammation according to the Modified Gingival Index (MGI).

Dental plaque

时间窗: 6 weeks

A reduction in the level of dental plaque according to Rustogi Modification of the Navy Plaque Index (RMNPI).

次要结局

  • Calculus(6 weeks)

研究者

发起方
Home Skinovations Ltd.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验